PMID- 28554528 OWN - NLM STAT- MEDLINE DCOM- 20180227 LR - 20180329 IS - 1873-6823 (Electronic) IS - 0741-8329 (Linking) VI - 61 DP - 2017 Jun TI - Lobeline attenuates ethanol abstinence-induced depression-like behavior in mice. PG - 63-70 LID - S0741-8329(16)30226-9 [pii] LID - 10.1016/j.alcohol.2017.01.015 [doi] AB - Evidence indicates that the brain nicotinic acetylcholine receptor (nAChRs) ligand lobeline reduces depression-like behaviors, ethanol drinking, and nicotine withdrawal-induced depression-like behaviors. The purpose of the present study was to determine the effects of lobeline on ethanol abstinence-induced depression-like behavior and associated neuroadaptive changes in mice. Adult C57BL/6J male mice were allowed to drink 10% ethanol for 4 weeks using a two-bottle choice procedure. Mice were tested after 24 h and 14 days of ethanol abstinence in a forced swim test (FST), a measure for depression-like behavior. Acute lobeline treatment (1 mg/kg) significantly reduced immobility time compared to controls after 24 h and 14 days of abstinence. In addition, abstinence from chronic ethanol exposure reduced serotonin levels in the hippocampus, which was reversed by acute lobeline treatment. Repeated lobeline treatment (1 mg/kg, once daily) for 14 days during ethanol abstinence also significantly reduced FST immobility in mice exposed to ethanol. Chronic ethanol exposure significantly reduced the number of 5-bromo 2'-deoxyuridine (BrdU)-positive cells in the dentate gyrus of the hippocampus, indicating decreased hippocampal cell proliferation. Abstinence from chronic ethanol exposure also decreased brain-derived neurotrophic factor (BDNF) in the dentate gyrus and CA3 region of the hippocampus. In contrast, repeated lobeline treatment significantly increased both BrdU- and BDNF-positive cells. Taken together, our results indicate that lobeline produced antidepressant-like effects, likely by targeting brain beta2-containing nAChRs, serotonergic neurotransmission, and/or hippocampal cell proliferation. Therefore, lobeline may have therapeutic utility to treat alcohol abstinence-induced depression. CI - Copyright (c) 2017 Elsevier Inc. All rights reserved. FAU - Roni, Monzurul Amin AU - Roni MA AD - Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, SD 57007, USA. FAU - Rahman, Shafiqur AU - Rahman S AD - Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, SD 57007, USA. Electronic address: shafiqur.rahman@sdstate.edu. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20170526 PL - United States TA - Alcohol JT - Alcohol (Fayetteville, N.Y.) JID - 8502311 RN - 0 (Antidepressive Agents) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 333DO1RDJY (Serotonin) RN - 3K9958V90M (Ethanol) RN - D0P25S3P81 (Lobeline) SB - IM MH - Alcohol Abstinence/*psychology MH - Alcohol Drinking/physiopathology MH - Animals MH - Antidepressive Agents MH - Behavior, Animal/*drug effects MH - Brain-Derived Neurotrophic Factor/analysis MH - Cell Proliferation/drug effects MH - Depression/*drug therapy/*etiology MH - Ethanol/administration & dosage MH - Hippocampus/chemistry/cytology/drug effects MH - Lobeline/*therapeutic use MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Serotonin/analysis MH - Swimming OTO - NOTNLM OT - Alcohol OT - Hippocampus OT - Lobeline OT - Major depression OT - Mice OT - Nicotinic receptor EDAT- 2017/05/31 06:00 MHDA- 2018/02/28 06:00 CRDT- 2017/05/31 06:00 PHST- 2016/09/06 00:00 [received] PHST- 2016/12/29 00:00 [revised] PHST- 2017/01/30 00:00 [accepted] PHST- 2017/05/31 06:00 [pubmed] PHST- 2018/02/28 06:00 [medline] PHST- 2017/05/31 06:00 [entrez] AID - S0741-8329(16)30226-9 [pii] AID - 10.1016/j.alcohol.2017.01.015 [doi] PST - ppublish SO - Alcohol. 2017 Jun;61:63-70. doi: 10.1016/j.alcohol.2017.01.015. Epub 2017 May 26.